Carbapenem-Based Antibiotics Market Size | Report 2021, 2028
The carbapenem-based antibiotics market size is expected to grow from US$ 3,964.57 million in 2021 to US$ 5,346.62 million by 2028; it is estimated to grow at a CAGR of 4.4% during 2021-2028.
Carbapenems are type of atypical β-lactam antibiotics that have wider antibacterial activity. Carbapenem-based antibiotics can cover many gram-positive, gram-negative aerobic, and anaerobic bacteria. Additionally, carbapenem-based antibiotics are stable to most β-lactamases. Hence, they are indicated as empiric monotherapy for various serious conditions, such as neutropenic infections and intra-abdominal infections.
The rising prevalence of gram-negative bacterial infections and the increasing production of generic drugs fuel the growth of the carbapenem-based antibiotics market. However, tedious and expensive process of antibiotic development restrains the market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Carbapenem-Based Antibiotics Market: Strategic Insights
Market Size Value in US$ 3,964.57 Million in 2021 Market Size Value by US$ 5,346.62 Million by 2028 Growth rate CAGR of 4.4% from 2021 to 2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Carbapenem-Based Antibiotics Market: Strategic Insights
| Market Size Value in | US$ 3,964.57 Million in 2021 |
| Market Size Value by | US$ 5,346.62 Million by 2028 |
| Growth rate | CAGR of 4.4% from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Rising Prevalence of Gram-Negative Bacterial Infections
Rising Prevalence of Gram-Negative Bacterial Infections
Gram-negative bacterial infections, such as urinary tract infection (UTI), pneumonia, bloodstream infections, wound or surgical site infections, and meningitis, are commonly acquired by patients during their hospital stays. These infections are generally known as hospital-acquired infections (HAI). Infections such as UTI and pneumonia are common in patients admitted to intensive care units. According to the US National Healthcare Safety Network, 30% of HAIs are caused by gram-negative bacteria, ~45% are due to UTI, and ~47% are by ventilator-associated pneumonia (VAP). The prevalence of infectious diseases caused by gram-negative bacteria is rapidly increasing.
In addition, gram-negative bacterial infections are resistant to multiple drugs and have developed better resistance to available antibiotics. Antimicrobial resistance (AMR) has become a global threat to modern medicine. Therefore, constant monitoring of emerging trends is required for the clinical isolates. A group of researchers in Latvia, Europe, has studied the progression of AMR for different gram-negative bacteria. As per the research article published by them in the MDPI journal in June 2021, carbapenem-based antibiotics such as Meropenem and Ertapenem were the most effective against gram-negative bacteria, showing 3% and 5.4% resistance rates, respectively. These antibiotics are globally accepted as a treatment for gram-negative bacteria. Therefore, it is estimated that the high demand for carbapenem-based antibiotics is likely to continue in the coming years.
According to the Centers for Disease Control and Prevention (CDC), the COVID-19 pandemic led to the rise in HAI cases in 2020. Hospital admissions have grown globally, which has increased the risk of VAP as a secondary infection for COVID-19 patients. This has resulted in fueled demand for carbapenem-based antibiotics, which is aiding the market significantly.
Type-Based Insights
The carbapenem-based antibiotics market, by type, is segmented into meropenem, doripenem, imipenem, tebipenem, and others. The others segment held the largest share of the carbapenem-based antibiotics market in 2021, and it is anticipated to register the highest CAGR in the market during the forecast period. The growing developments for carbapenem-based antibiotics are likely to drive the market growth in the future.
Indication-Based Insights
By indication, the carbapenem-based antibiotics market is segmented into bacterial meningitis, acute pelvic infections, respiratory tract infections, intra-abdominal infections, urinary tract infections, and others. The others segment held the largest share of the carbapenem-based antibiotics market in 2021, and it is estimated to register the highest CAGR in the market during the forecast period. The uncertainty of bacterial infections propels the demand for carbapenem-based antibiotics, which is expected to drive the growth of market in the coming years.
Carbapenem-Based Antibiotics Market Report Scope
Distribution Channel-Based Insights
By distribution channel, the carbapenem-based antibiotics market is segmented into retail pharmacies, online pharmacies, and hospital pharmacies. The hospital pharmacies segment held the largest share of the carbapenem-based antibiotics market in 2021, and it is estimated to register the highest CAGR in the market during the forecast period.
Organic strategies, such as new product launch, is commonly adopted by companies to expand their product portfolios in the market. Moreover, the companies have implemented various inorganic strategies, such as mergers and acquisitions and partnerships. For instance, in May 2021, Gland Pharma Limited in association with Dr Reddy's Laboratories Ltd launched Ertapenem for Injection, 1 g/vial, a therapeutic equivalent to generic version of INVANZ (ertapenem for injection) for injection) 1 g/vial, which is approved by the US Food and Drug Administration (USFDA).
Company Profiles
- Pfizer Inc.
- Savior Lifetec
- Sumitomo Dainippon Pharma Co., Ltd.
- Merck & Co., Inc.
- Gland Pharma Limited
- Aurobindo Pharma Ltd
- DAEWOONG PHARMACEUTICAL CO.,LTD
- Iterum Therapeutics plc
- ACS Dobfar S.p.A
- Spero Therapeutics
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Indication, and Distribution Channel
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The carbapenem-based antibiotics market is analyzed in the basis of type, indication, and distribution channel. Based on type, is segmented into meropenem, doripenem, imipenem, tebipenem, and others. The others segment held the largest share of the market, and it is anticipated to register the highest CAGR. Based indication, the market is segmented as bacterial meningitis, acute pelvic infections, respiratory tract infections, intra-abdominal infections, urinary tract infections, and others. The others segment held the largest share of the market, and it is estimated to register the highest CAGR. And based on distribution channel, the market is divided into retail pharmacies, online pharmacies, and hospital pharmacies. The hospital pharmacies segment held the largest share of the market, and it is estimated to register the highest CAGR.
The carbapenem-based antibiotics market majorly consists of the players such as Pfizer Inc.; Savior Lifetec; Sumitomo Dainippon Pharma Co., Ltd.; Merck & Co., Inc.; Gland Pharma Limited; Aurobindo Pharma Ltd; Daewoong Pharmaceutical Co.,Ltd; Iterum Therapeutics plc; ACS Dobfar S.p.A, and Spero Therapeutics among others.
Carbapenems are type of atypical β-lactam antibiotics that have wider antibacterial activity. Carbapenem-based antibiotics can cover many gram-positive, gram-negative aerobic, anaerobic bacteria. Additionally, carbapenem-based antibiotics are stable to most β-lactamases and hence, are indicated as empiric monotherapy for various serious conditions such as neutropenic infections and intra-abdominal infections.
The factors that are driving the growth of market are growing rising prevalence of gram-negative bacterial infections and increasing production of generic drugs fuel the growth of the market. However, the tedious and expensive process of antibiotic development, as well as approval, is the major factor hindering the market growth.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Carbapenem-based Antibiotics Market – By Type
1.3.2 Global Carbapenem-based Antibiotics Market – By Indication
1.3.3 Global Carbapenem-based Antibiotics Market – By Distribution Channel
1.3.4 Global Carbapenem-based Antibiotics Market – By Geography
2. Carbapenem-based Antibiotics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Carbapenem-based Antibiotics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America– PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East and Africa– PEST Analysis
4.2.5 South and Central America– PEST Analysis
4.3 Expert Opinions
5. Carbapenem-based Antibiotics Market – Key Market Dynamics
5.1 Drivers
5.1.1 Rising Prevalence of Gram-Negative Bacterial Infections
5.1.2 Increasing Production of Generic Drugs
5.2 Market Restraints
5.2.1 Tedious and Expensive Process of Antibiotic Development
5.3 Market Opportunities
5.3.1 Private and Public Partnerships
5.4 Future Trends
5.4.1 Strategic Advancement for New Antibiotic Identification
5.5 Impact Analysis
6. Carbapenem-based Antibiotics Market – Global Analysis
6.1 Global Carbapenem-based Antibiotics Market Revenue Forecast and Analysis
6.2 Global Carbapenem-based Antibiotics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Carbapenem-based Antibiotics Market Analysis – By Type
7.1 Overview
7.2 Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)
7.3 Meropenem
7.3.1 Overview
7.3.2 Meropenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Doripenem
7.4.1 Overview
7.4.2 Doripenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Imipenem
7.5.1 Overview
7.5.2 Imipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Tebipenem
7.6.1 Overview
7.6.2 Tebipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8. Carbapenem-based Antibiotics Market – By Indication
8.1 Overview
8.2 Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)
8.3 Bacterial Meningitis
8.3.1 Overview
8.3.2 Bacterial Meningitis: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Acute Pelvic Infections
8.4.1 Overview
8.4.2 Acute Pelvic Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Respiratory Tract Infections
8.5.1 Overview
8.5.2 Respiratory Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Intra-abdominal Infections
8.6.1 Overview
8.6.2 Intra-abdominal Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Urinary Tract Infections
8.7.1 Overview
8.7.2 Urinary Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
9. Carbapenem-based Antibiotics Market – By Distribution Channel
9.1 Overview
9.2 Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)
9.3 Retail Pharmacies
9.3.1 Overview
9.3.2 Retail Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Online Pharmacies
9.4.1 Overview
9.4.2 Online Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Hospital Pharmacies
9.5.1 Overview
9.5.2 Hospital Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
10. Carbapenem-based Antibiotics Market – Regional Analysis
10.1 North America: Carbapenem-based Antibiotics Market
10.1.1 Overview
10.1.2 North America: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.3 North America: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.1.4 North America: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)
10.1.5 North America: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)
10.1.6 North America: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.1.1 US: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.1.2 US: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.1.6.1.3 US: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.1.6.1.4 US: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.1.6.2 Canada: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.2.1 Canada: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.2.2 Canada: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.1.6.2.3 Canada: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.1.6.2.4 Canada: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.1.6.3 Mexico: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.3.1 Mexico: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.3.2 Mexico: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.1.6.3.3 Mexico: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.1.6.3.4 Mexico: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.2 Europe: Carbapenem-based Antibiotics Market
10.2.1 Overview
10.2.2 Europe: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.3 Europe: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.2.4 Europe: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)
10.2.5 Europe: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)
10.2.6 Europe: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
10.2.6.1 UK: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.1.1 UK: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.1.2 UK: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.2.6.1.3 UK: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.2.6.1.4 UK: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.2.6.2 Germany: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.2.1 Germany: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.2.2 Germany: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.2.6.2.3 Germany: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.2.6.2.4 Germany: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.2.6.3 France: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.3.1 France: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.3.2 France: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.2.6.3.3 France: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.2.6.3.4 France: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.2.6.4 Italy: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.4.1 Italy: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.4.2 Italy: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.2.6.4.3 Italy: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.2.6.4.4 Italy: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.2.6.5 Spain: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.5.1 Spain: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.5.2 Spain: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.2.6.5.3 Spain: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.2.6.5.4 Spain: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.2.6.6 Rest of Europe: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.6.1 Rest of Europe: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.2.6.6.2 Rest of Europe: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.2.6.6.3 Rest of Europe: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.2.6.6.4 Rest of Europe: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.3 Asia Pacific: Carbapenem-based Antibiotics Market
10.3.1 Overview
10.3.2 Asia Pacific: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.3 Asia Pacific: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.3.4 Asia Pacific: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)
10.3.5 Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)
10.3.6 Asia Pacific: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.1.1 China: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.1.2 China: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.3.6.1.3 China: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.3.6.1.4 China: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.3.6.2 Japan: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.2.1 Japan: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.2.2 Japan: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.3.6.2.3 Japan: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.3.6.2.4 Japan: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.3.6.3 India: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.3.1 India: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.3.2 India: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.3.6.3.3 India: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.3.6.3.4 India: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.3.6.4 Australia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.4.1 Australia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.4.2 Australia: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.3.6.4.3 Australia: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.3.6.4.4 Australia: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.3.6.5 South Korea: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.5.1 South Korea: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.5.2 South Korea: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.3.6.5.3 South Korea: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.3.6.5.4 South Korea: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.3.6.6 Rest of Asia Pacific: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.6.1 Rest of Asia Pacific: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.3.6.6.2 Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.3.6.6.3 Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.3.6.6.4 Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.4 Middle East and Africa: Carbapenem-based Antibiotics Market
10.4.1 Overview
10.4.2 Middle East and Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.3 Middle East and Africa: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.4.4 Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)
10.4.5 Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)
10.4.6 Middle East and Africa: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
10.4.6.1 UAE: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.1.1 UAE: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.1.2 UAE: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.4.6.1.3 UAE: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.4.6.1.4 UAE: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.4.6.2 Saudi Arabia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.2.1 Saudi Arabia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.2.2 Saudi Arabia: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.4.6.2.3 Saudi Arabia: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.4.6.2.4 Saudi Arabia: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.4.6.3 South Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.3.1 South Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.3.2 South Africa: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.4.6.3.3 South Africa: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.4.6.3.4 South Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.4.6.4 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.4.1 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.4.2 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.4.6.4.3 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.4.6.4.4 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.5 South and Central America: Carbapenem-based Antibiotics Market
10.5.1 Overview
10.5.2 South and Central America: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.5.3 South and Central America: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.5.4 South and Central America: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)
10.5.5 South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)
10.5.6 South and Central America: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
10.5.6.1 Brazil: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.5.6.1.1 Brazil: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.5.6.1.2 Brazil: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.5.6.1.3 Brazil: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.5.6.1.4 Brazil: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.5.6.2 Argentina: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.5.6.2.1 Argentina: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.5.6.2.2 Argentina: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.5.6.2.3 Argentina: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.5.6.2.4 Argentina: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.5.6.3 Rest of South and Central America: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.5.6.3.1 Rest of South and Central America: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.5.6.3.2 Rest of South and Central America: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.5.6.3.3 Rest of South and Central America: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.5.6.3.4 Rest of South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
11. Impact of COVID-19 Pandemic on Global Carbapenem-based Antibiotics Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Carbapenem-based Antibiotics Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Carbapenem-based Antibiotics Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. COMPANY PROFILES
13.1 ACS Dobfar S.p.A
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Iterum Therapeutics plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 DAEWOONG PHARMACEUTICAL CO.,LTD
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Aurobindo Pharma Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Gland Pharma Limited
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Merck & Co., Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Sumitomo Dainippon Pharma Co., Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Savior Lifetec
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Pfizer Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Spero Therapeutics
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 2. North America: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 4. US: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 5. US: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 6. US: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 7. Canada: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 8. Canada: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 9. Canada: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 10. Mexico: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 11. Mexico: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 12. Mexico: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 13. Europe: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 14. Europe: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 15. Europe: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 16. UK: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 17. UK: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 18. UK: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 19. Germany: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 20. Germany: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 21. Germany: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 22. France: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 23. France: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 24. France: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 25. Italy: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 26. Italy: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 27. Italy: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 28. Spain: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 29. Spain: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 30. Spain: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 31. Rest of Europe: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 32. Rest of Europe: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 33. Rest of Europe: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 34. Asia Pacific: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 35. Asia Pacific: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 36. Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 37. China: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 38. China: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 39. China: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 40. Japan: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 41. Japan: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 42. Japan: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 43. India: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 44. India: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 45. India: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 46. Australia: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 47. Australia: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 48. Australia: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 49. South Korea: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 50. South Korea: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 51. South Korea: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 52. Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 53. Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 54. Rest of Asia Pacific: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 55. Middle East and Africa: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 56. Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 57. Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 58. UAE: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 59. UAE: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 60. UAE: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 61. Saudi Arabia: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 62. Saudi Arabia: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 63. Saudi Arabia: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 64. South Africa: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 65. South Africa: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 66. South Africa: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 67. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 68. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 69. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 70. South and Central America: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 71. South and Central America: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 72. South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 73. Brazil: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 74. Brazil: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 75. Brazil: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 76. Argentina: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 77. Argentina: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 78. Argentina: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 79. Rest of South and Central America: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 80. Rest of South and Central America: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 81. Rest of South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 82. Organic Developments in the Carbapenem-based Antibiotics Market
Table 83. Inorganic Developments in the Carbapenem-based Antibiotics Market
Table 84. Glossary of Terms, Carbapenem-based Antibiotics Market
LIST OF FIGURES
Figure 1. Carbapenem-based Antibiotics Market Segmentation
Figure 2. Carbapenem-based Antibiotics Segmentation, By Region
Figure 3. Global Carbapenem-based Antibiotics Market Overview
Figure 4. The Others Segment Held Largest Share of Type Segment in Carbapenem-based Antibiotics Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Carbapenem-based Antibiotics Market, By Geography (US$ Million)
Figure 7. Global Carbapenem-based Antibiotics Market- Leading Country Markets (US$ Million)
Figure 8. Global Carbapenem-based Antibiotics Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Carbapenem-based Antibiotics Market Impact Analysis of Driver and Restraints
Figure 15. Global Carbapenem-based Antibiotics Market – Revenue Forecast and Analysis – 2021- 2028
Figure 16. Global Carbapenem-based Antibiotics Market – By Geography Forecast and Analysis – 2021- 2028.
Figure 17. Market Positioning of Key Players in Global Carbapenem-based Antibiotics Market
Figure 18. Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)
Figure 19. Meropenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Doripenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Imipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Tebipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)
Figure 25. Bacterial Meningitis: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Acute Pelvic Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Respiratory Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Intra-abdominal Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Urinary Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)
Figure 32. Retail Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Online Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Hospital Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. North America: Carbapenem-based Antibiotics Market, by Key Country – Revenue (2021) (US$ ‘Million)
Figure 36. North America: Carbapenem-based Antibiotics Market Revenue and Forecast to 2028 (US$ ‘Million)
Figure 37. North America: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
Figure 38. US: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 39. Canada: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 40. Mexico: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 41. Europe: Carbapenem-based Antibiotics Market, by Key Country – Revenue (2021) (US$ ‘Million)
Figure 42. Europe: Carbapenem-based Antibiotics Market Revenue and Forecast to 2028 (US$ ‘Million)
Figure 43. Europe: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
Figure 44. UK: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 45. Germany: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 46. France: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 47. Italy: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 48. Spain: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 49. Rest of Europe: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 50. Asia Pacific: Carbapenem-based Antibiotics Market, by Key Country – Revenue (2021) (US$ ‘Million)
Figure 51. Asia Pacific: Carbapenem-based Antibiotics Market Revenue and Forecast to 2028 (US$ ‘Million)
Figure 52. Asia Pacific: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
Figure 53. China: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 54. Japan: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 55. India: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 56. Australia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 57. South Korea: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 58. Rest of Asia Pacific: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 59. Middle East and Africa: Carbapenem-based Antibiotics Market, by Key Country – Revenue (2021) (US$ ‘Million)
Figure 60. Middle East and Africa: Carbapenem-based Antibiotics Market Revenue and Forecast to 2028 (US$ ‘Million)
Figure 61. Middle East and Africa: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
Figure 62. UAE: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 63. Saudi Arabia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 64. South Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 65. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 66. South and Central America: Carbapenem-based Antibiotics Market, by Key Country – Revenue (2021) (US$ ‘Million)
Figure 67. South and Central America: Carbapenem-based Antibiotics Market Revenue and Forecast to 2028 (US$ ‘Million)
Figure 68. South and Central America: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
Figure 69. Brazil: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 70. Argentina: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 71. Rest of South and Central America: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 72. Impact Of COVID-19 Pandemic in North American Country Markets
Figure 73. Impact Of COVID-19 Pandemic in Europe Country Markets
Figure 74. Impact Of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 75. Impact Of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 76. Impact Of COVID-19 Pandemic in South and Central America Country Markets
Figure 77. Growth Strategies in the Carbapenem-based Antibiotics Market (%)
The List of Companies - Carbapenem Based Antibiotics Market
- Pfizer Inc.
- Savior Lifetec
- Sumitomo Dainippon Pharma Co., Ltd.
- Merck & Co., Inc.
- Gland Pharma Limited
- Aurobindo Pharma Ltd
- Daewoong Pharmaceutical Co.,Ltd,
- Iterum Therapeutics plc
- ACS Dobfar S.p.A
- Spero Therapeutics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For